Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Uter, Wolfgang
- dc.contributor.author Giménez Arnau, Anna Maria
- dc.contributor.author ESSCA Working Group
- dc.date.accessioned 2021-09-09T06:58:16Z
- dc.date.available 2021-09-09T06:58:16Z
- dc.date.issued 2021
- dc.description.abstract Background: Clinical surveillance of the prevalence of contact allergy in consecutively patch tested patients is a proven instrument to continually assess the importance of contact allergens (haptens) assembled in a baseline series. Objectives: To present current results from the European Surveillance System on Contact Allergies, including 13 countries represented by 1 to 11 departments. Methods: Anonymized or pseudonymized patch test and clinical data from various data capture systems used locally or nationally as transferred to the Erlangen data centre were pooled and descriptively analysed after quality control. Results: In the 4 years (2015-2018), data from 51 914 patients patch tested with the European baseline series (EBS) of contact allergens were analysed. Contact allergy to nickel was most frequent (17.6% positive), followed by contact allergy to fragrance mix I (6.9%), methylisothiazolinone (MI; 6.2%), and Myroxylon pereirae resin (balsam of Peru; 5.8%). Conclusions: While the prevalence of MI contact allergy decreased substantially following regulatory intervention, the persistently high levels of allergy to metals, fragrances, other preservatives, and rubber chemicals point to problems needing further research and, potentially, preventive efforts. Results with national additions to the baseline series provide important information on substances possibly to be considered for inclusion in the EBS.
- dc.format.mimetype application/pdf
- dc.identifier.citation Uter W, Bauer A, Belloni Fortina A, Bircher AJ, Brans R, Buhl T et al. Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018. Contact Dermatitis. 2021;84(2):109-20. DOI: 10.1111/cod.13704
- dc.identifier.doi http://dx.doi.org/10.1111/cod.13704
- dc.identifier.issn 0105-1873
- dc.identifier.uri http://hdl.handle.net/10230/48416
- dc.language.iso eng
- dc.publisher Wiley
- dc.relation.ispartof Contact Dermatitis. 2021;84(2):109-20
- dc.rights © 2020 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword RRID:SCR_001905
- dc.subject.keyword Clinical epidemiology
- dc.subject.keyword Contact allergy
- dc.subject.keyword Patch testing
- dc.subject.keyword Surveillance
- dc.title Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion